Business Value: Xenon Corp (XENE)
This chart of Xenon Pharmaceuticals (XENE) quotes on GURU.Markets demonstrates an Enterprise Value of 2711.12. Xenon Pharmaceuticals (XENE) operates through Canadian R&D centers, outsourcing drug manufacturing to third-party contractors. Operational continuity is ensured by strictly controlled, specialized transportation of components. The success of this epilepsy treatment developer is directly determined by test results and approval from relevant regulatory authorities.
%20Enterprise%20Value&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_XENE_-_Xenon-Pharmaceuticals_-_Enterprise-Value "Xenon - XENE Total Enterprise Value (period 11/23/2025 - 10/30/2026) | 👁️GURU.Markets👁️")
Xenon Pharmaceuticals - analytical breakdowns and key metrics (XENE)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
- earnings and market multiples details:
Analysis of all company metrics:Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (XENE) investments in laboratory greening and renewable energy require strict control of capital expenditures. Enterprise Value (EV) sums market capitalization and net debt, allowing an investor to determine the actual acquisition cost of the company accounting for all liabilities and cash reserves, which is reflected in the price action of this enterprise value.
Competitors of Xenon Pharmaceuticals (XENE)
Biogen Inc (BIIB) - Total Enterprise Value|NBIX - Total Company Value|RGC (Regencell Corp) - Business Value|AXSM: Enterprise Value|Total Enterprise Value acadia-pharm.com (ACAD)|Total Company Value Viking Therapeutics, Inc.|Business Value SUPN (Supernus Pharmaceuticals, Inc.)|Enterprise Value CPRX|DNLI - Total Enterprise Value|Harmony Biosciences - Real Price to Acquire Entire Company|Enterprise Value biohavenpharma.com BHVN|AMLX - Total Company Value|Value Adjusted for Debt and Cash TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Total Company Value|Total Enterprise Value Anavex Life Sciences Corp (AVXL)|Real Price to Acquire Entire Company CBLL|Business Value PRTA (Prothena Corp)|Enterprise Value ALEC|ANNX - Total Enterprise Value|Total Company Value Omeros OMER|NGNE: Business Value|ACIU - Total Company Value|Total Enterprise Value voyagertherapeutics.com|Neumora Therapeutics, Inc. (NMRA) - Total Company Value|Business Value SCLX|Real Price to Acquire Entire Company TVGN|ACOG: Value Adjusted for Debt and Cash|Total Company Value Cognition Therapeutics, Inc. (CGTX)|IKT: Full Business Value|Enterprise Value SAVA (Cassava Sciences)|Value Adjusted for Debt and Cash ASRT|Coya - Enterprise Value|VTGN - Enterprise Value|ovidrx.com (OVID) - Total Company Value|acumenpharm.com - Value Adjusted for Debt and Cash|Total Company Value CervoMed|Real Price to Acquire Entire Company Alterity Therapeutics Ltd (ATHE)|Enterprise Value CLNN|Enterprise Value pepgen.com (PEPG)|Enterprise Value JUNS (Jupiter Neurosciences)|RLMD - Real Price to Acquire Entire Company|Annovis Bio - Enterprise Value|Total Enterprise Value Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience Inc) - Real Price to Acquire Entire Company|Klotho Neurosciences (KLTO) - Enterprise Value|Real Price to Acquire Entire Company NRSN|RVPH (revivapharma.com) - Aggregate Business Value|Enterprise Value MTVA|Company Buyout Price NeurAxis Inc.|Enterprise Value HSDT (Helius Medical Technologies)|PASG - Real Price to Acquire Entire Company|Neuphoria - Enterprise Value|NERV - Enterprise Value|Athira Pharma (ATHA) - Total Company Value|ADXN (Addex Therapeutics Ltd.) - Total Company Value|Total Company Value Alzamend Neuro Inc.|Cyclerion (CYCN) - Company Buyout Price|Real Price to Acquire Entire Company PTIX (Protagenic Therapeutics)|pasitheaclinics.com - Business Value|Enterprise Value CRGT (Cortigent)|Avenue Therapeutics Inc. (ATXI) - Total Enterprise Value|BCLI - Total Company Value|CARA (Cara Therapeutics Inc) - Business Value|CHRO: Enterprise Value|Total Enterprise Value Eliem Therapeutics Inc. (ELYM)|Total Company Value Intra-Cellular Therapies Inc.|Business Value LBPH (Longboard Pharmaceuticals Inc)|Enterprise Value MRNS|NKGN - Total Enterprise Value|NeuroBo Pharmaceuticals - Real Price to Acquire Entire Company|Enterprise Value sagerx.com SAGE|SNPX - Total Company Value|Value Adjusted for Debt and Cash TRVN (Trevena Inc.)|vigilneuro.com (VIGL) - Total Company Value|Total Enterprise Value anewmeds.com (WENA)|Real Price to Acquire Entire Company CERE